ARA-290 - 16mg

ARA 290 is a next-generation peptide derived from erythropoietin (EPO) that delivers powerful anti-inflammatory, neuroprotective, and tissue-healing support—without stimulating excess red blood cell production. Expect faster recovery, calmer inflammation, nerve support, and better everyday performance.

Peptide Profile

• Peptide Name: ARA 290 (Cibinetide)
• CAS Number: 1208243-50-8
• Molecular Formula: C₅₁H₈₄N₁₆O₂₁
• Main Function: Anti-inflammatory, neuroprotective, tissue-regenerating peptide
• Mechanism of Action: Selectively engages the erythropoietin/CD131 “innate repair receptor” (IRR), activating protective and regenerative pathways without driving erythropoiesis.

Key Features & Benefits

• Helps reduce neuropathic pain and sensitivity
• Supports nerve regeneration and function
• Calms systemic inflammation and protects tissues
• Promotes wound healing and recovery after stress or training
• Supports kidney and cardiometabolic wellness
• Backed by human studies in small-fiber neuropathy and sarcoidosis-related symptoms
• Generally well-tolerated with a favorable safety profile

Best For: Individuals seeking relief from neuropathic discomfort, chronic inflammation, recovery support after injury or training, and overall wellness optimization.

Effects on Key Areas

• Blood Sugar & Metabolism: Supports healthy metabolic signaling.
• Muscle & Endurance: Aids post-training recovery and tissue repair.
• Joints & Tendons: Helps calm inflammatory stress and promote healing.
• Nervous System: Neuroprotective; supports small-fiber nerve health.
• Anti-Aging & Wellness: Cellular protection pathways that promote resilience.

Recommended Dosage & Administration

• Typical Range (research-based): 2–6 mg subcutaneously per day
• Cycle Length: Commonly 4 weeks; some protocols extend to 6–8 weeks depending on goals and response
• Dosing Tips: May be taken as a single daily dose or split AM/PM
• Administration: Subcutaneous injection; rotate sites to minimize irritation

Sample 6-Week Plan

1. Weeks 1–2: 2 mg daily (assess tolerance and response)
2. Weeks 3–6: 3–4 mg daily (adjust within 2–6 mg/day as needed)

After completion, take a short break; cycles may be repeated based on goals.

What Is ARA 290?

ARA 290 (Cibinetide) is a synthetic, non-erythropoietic analog inspired by the helix-B region of EPO. It targets the innate repair receptor (IRR) to switch on built-in protective programs—reducing inflammation, shielding nerves from damage, and accelerating natural repair without raising hematocrit.

Benefits

• Injury and tissue healing support
• Joint and tendon comfort during training blocks
• Neuroprotection for small-fiber nerves
• Systemic anti-inflammatory support
• Bone and muscle recovery after high workloads
• Improved endurance recovery and performance
• Healthy aging and overall wellness reinforcement

Clinical Trials & Research

• Small-Fiber Neuropathy (Sarcoidosis): Daily subcutaneous ARA 290 over ~4 weeks improved neuropathic symptoms, small-fiber nerve density, sensory thresholds, and exercise capacity.
• Neuropathic Pain & Quality of Life: Human studies report reductions in pain scores and gains in physical functioning and well-being.
• Broader Potential: Early research suggests tissue-protective and metabolic benefits; larger trials are ongoing.

Applications in Sports & Fitness

• Accelerated recovery after hard training
• Tendon and joint comfort through inflammation control
• Neural support for consistent performance
• Tissue-repair support during high-volume phases

Possible Side Effects

• Mild, temporary injection-site discomfort
• Infrequent, transient changes in blood pressure or blood sugar
• Rare hypersensitivity reactions (rash, swelling, breathing difficulty)

Conclusion

ARA 290 (Cibinetide) delivers a high-value combination of inflammation control, nerve protection, and repair support. It’s a smart choice for athletes and high performers looking to reduce pain, recover faster, and elevate wellness—confident, clean, and targeted.

FAQs

• What is ARA 290? A non-erythropoietic EPO-derived peptide that reduces inflammation, protects nerves, and promotes tissue healing.
• What are the key benefits? Reduced neuropathic pain, calmer inflammation, supported nerve function, faster recovery.
• Who can use it? Active individuals and high performers seeking nerve, joint, and recovery support.
• How do I take it? Subcutaneous injection once daily (or split), typically 2–6 mg/day for ~4–6 weeks.
• Are there side effects? Mostly mild and temporary; rare allergic responses possible.
• Is it legal? Regulatory status varies; check local guidelines.
• Why choose Nordic Peptides? Premium purity, consistent potency, performance-driven results.

Ready to accelerate recovery and protect your nerves? Order Nordic Peptides ARA 290 (Cibinetide) today and feel the difference in performance and wellness.